Compare NGL & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NGL | INMD |
|---|---|---|
| Founded | 1940 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 751.7M | 879.2M |
| IPO Year | 2011 | 2019 |
| Metric | NGL | INMD |
|---|---|---|
| Price | $10.01 | $14.49 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $16.75 |
| AVG Volume (30 Days) | 252.9K | ★ 499.8K |
| Earning Date | 02-09-2026 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.42 |
| EPS | N/A | ★ 2.21 |
| Revenue | ★ $3,250,313,000.00 | $364,494,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.76 |
| P/E Ratio | ★ N/A | $6.54 |
| Revenue Growth | ★ 46.95 | N/A |
| 52 Week Low | $2.64 | $13.14 |
| 52 Week High | $10.29 | $19.78 |
| Indicator | NGL | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 56.61 | 51.33 |
| Support Level | $9.45 | $14.30 |
| Resistance Level | $10.15 | $14.60 |
| Average True Range (ATR) | 0.30 | 0.24 |
| MACD | -0.06 | 0.02 |
| Stochastic Oscillator | 55.03 | 51.11 |
NGL Energy Partners LP is a USA-based firm that owns and operates a vertically integrated energy business. The company's operating segments include Crude Oil Logistics, Water Solutions, and Liquids Logistics. It operates crude oil Logistics, owns pipeline injection stations, and offers services for the treatment and disposal of wastewater generated from crude oil and natural gas production, as well as for the disposal of solids, such as tank bottoms and drilling fluids. The firm also supplies natural gas liquids to retailers, wholesalers, refiners, and petrochemical plants and sells propane and distillates.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.